Chairman and CEO Liang Wenqing Increases Stake in CF PharmTech (02652) by 19,300 Shares at Approximately HK$6.92 Per Share
Stock News
2 hours ago
According to the latest data from the Hong Kong Stock Exchange, on October 6, Chairman and CEO Liang Wenqing increased his holdings in CF PharmTech (02652) by 19,300 shares at a price of HK$6.9216 per share, for a total amount of approximately HK$133,600.
Following the increase, his latest shareholding stands at approximately 60,716,500 shares, representing an 18.74% stake in the company.
Supplementary information: Pursuant to the Acting-in-Concert Agreement, Dr. LIANG Bill Wenqing and Dr. LI LI BOVET are parties acting in concert. As such, under the SFO, each of Dr. LIANG and Dr. LI LI BOVET is deemed to be interested in the shares the other is interested in.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.